Mu Lai An - Net Worth and Insider Trading

Mu Lai An Net Worth

The estimated net worth of Mu Lai An is at least $0 dollars as of 2025-04-10. Mu Lai An is the Director of Shanghai Kaibao Pharmaceutical Co Ltd and owns about 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) stock worth over $0. Details can be seen in Mu Lai An's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mu Lai An has not made any transactions after 2015-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Mu Lai An

To

Mu Lai An Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mu Lai An owns 1 companies in total, including Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) .

Click here to see the complete history of Mu Lai An’s form 4 insider trades.

Insider Ownership Summary of Mu Lai An

Ticker Comapny Transaction Date Type of Owner
SZSE:300039 Shanghai Kaibao Pharmaceutical Co Ltd 2015-07-17 Director

Mu Lai An Latest Holdings Summary

Mu Lai An currently owns a total of 1 stock. Mu Lai An owns 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) as of July 17, 2015, with a value of $0.

Latest Holdings of Mu Lai An

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300039 Shanghai Kaibao Pharmaceutical Co Ltd 2015-07-17 0 6.10 0

Holding Weightings of Mu Lai An


Mu Lai An Form 4 Trading Tracker

According to the SEC Form 4 filings, Mu Lai An has made a total of 0 transactions in Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) over the past 5 years. The most-recent trade in Shanghai Kaibao Pharmaceutical Co Ltd is the acquisition of 42,600 shares on July 17, 2015, which cost Mu Lai An around $788,100.

Insider Trading History of Mu Lai An

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mu Lai An Trading Performance

GuruFocus tracks the stock performance after each of Mu Lai An's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mu Lai An is -27.56%. GuruFocus also compares Mu Lai An's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mu Lai An within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mu Lai An's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mu Lai An

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.85 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Mu Lai An Ownership Network

Ownership Network List of Mu Lai An

No Data

Ownership Network Relation of Mu Lai An

Insider Network Chart

Mu Lai An Owned Company Details

What does Shanghai Kaibao Pharmaceutical Co Ltd do?

Who are the key executives at Shanghai Kaibao Pharmaceutical Co Ltd?

Mu Lai An is the Director of Shanghai Kaibao Pharmaceutical Co Ltd. Other key executives at Shanghai Kaibao Pharmaceutical Co Ltd include Secretary Dong Ren Li Wang , Supervisors Liu Shao Yong , and Executives Zhang Tao .

Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shanghai Kaibao Pharmaceutical Co Ltd Insider Transactions

No Available Data

Mu Lai An Mailing Address

Above is the net worth, insider trading, and ownership report for Mu Lai An. Currently GuruFocus does not have mailing address information for Mu Lai An.